Is Palantir Stock a Buy After Its Beat-And-Raise Quarter?
Palantir stock is rallying Tuesday after the data analytics firm beat Q2 earnings estimates and raised its full-year outlook. Here's what you need to know.


Palantir Technologies (PLTR) stock is soaring Tuesday after the data analytics firm beat top- and bottom-line expectations for its second quarter and raised its full-year revenue forecast.
In the three months ended June 30, Palantir's revenue increased 27.2% year-over-year to $678.1 million, driven by 54.6% growth from U.S. commercial customers to $159.2 million and strong growth in its Artificial Intelligence Platform (AIP). Its earnings per share (EPS) improved to 9 cents from 5 cents in the year-ago period, up 80%.
"The growth of our business has been re-accelerating steadily, and we see an unprecedented opportunity ahead to capture and build on that momentum," wrote Palantir CEO Alex Karp in his letter to shareholders. "Our growth across the commercial and government markets has been driven by an unrelenting wave of demand from customers for artificial intelligence systems that go beyond the merely performative and academic."

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The results surpassed analysts" expectations. Wall Street was anticipating revenue of $653 million and earnings of 8 cents per share, according to MarketWatch.
As a result of its strong performance in the first half of 2024, Palantir raised its full-year revenue forecast. The company now anticipates revenue to arrive between $2.742 billion to $2.75 billion, up from its previous forecast of revenue in the range of $2.677 billion to $2.689 billion. The revised outlook includes U.S. commercial revenue growth of at least 47% to over $672 million, up from its prior guidance for growth of at least 45% to over $661 million.
Is Palantir stock a buy, sell or hold?
Although Palantir is up 51% for the year to date, Wall Street is on the sidelines when it comes to the tech stock. According to S&P Global Market Intelligence, the average analyst target price for PLTR stock is $24.56, representing a discount of roughly 7% to current levels. Additionally, the consensus recommendation is Hold.
Still, there are some bulls to be found, including in financial services firm Wedbush, which has with an Outperform rating (equivalent to a Buy). The group also hiked its price target on Palantir after earnings.
"We are raising our price target to $38 from $35 as the AIP story now takes hold for the Palantir story," said Wedbush analyst Daniel Ives in a note. "We maintain our Outperform rating with our bull case $50. This was a game changer quarter for the Palantir story as the AIP monetization piece on U.S. commercial was front and center as a major growth driver."
Wedbush's $38 price target is the highest on Wall Street and sits 44% higher than where Palantir is currently trading.
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
7 Things You Should Do Now if You Think Your Identity Was Stolen
If you suspect your identity was stolen, there are several steps you can take to protect yourself, but make sure you take action fast.
-
Dow Hits New Intraday High: Stock Market Today
Value-hunters with big stakes in a particular component kept one of the main U.S. equity indexes in positive territory.
-
Dow Hits New Intraday High: Stock Market Today
Value-hunters with big stakes in a particular component kept one of the main U.S. equity indexes in positive territory.
-
Berkshire Buys the Dip on UnitedHealth Group Stock. Should You?
Buffett & Co. picked up UnitedHealth stock on the cheap, with the embattled blue chip one of the newest holdings in the Berkshire Hathaway equity portfolio.
-
Mutual Funds Are About to Get the ETF Treatment. Here's What It Means for Investors
The SEC is expected to decide soon whether mutual funds from dozens of providers can be offered as ETF share classes.
-
Thanks to the OBBB, Now Could Be the Best Tax-Planning Window We've Had: 12 Things You Should Know
The new tax legislation offers unique opportunities to make smart financial moves and save on taxes, especially for people nearing or in retirement with significant savings.
-
Market Rebounds Are Happening Fast: Should You Buy the Dips? A Financial Planner's Guide
Markets are bouncing back faster than ever. For some long-term investors, that could mark a compelling case for systematic investing during downturns.
-
Markets Weigh Earnings and Inflation: Stock Market Today
The major U.S. indexes struggled Thursday amid a hot inflation reading and seasonal headwinds.
-
Bullish, Deere and dLocal: Thursday's Biggest Movers
BLSH stock is continuing its post-IPO climb, while Deere and dLocal are swinging post-earnings.
-
What Set Warren Buffett Apart
As Warren Buffett prepares for retirement, we reflect on what we've learned from his 60 years of leadership at Berkshire Hathaway.